(Q46978937)

27 December 2017

title

Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils (English)

1 reference

27 December 2017

0 references

Ray I

1

1 reference

27 December 2017

Chauhan A

series ordinal

2

1 reference

27 December 2017

Wegiel J

series ordinal

3

1 reference

27 December 2017

Chauhan VP

series ordinal

4

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

27 December 2017

published in

Brain Research

1 reference

27 December 2017

volume

853

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

344-351

1 reference

27 December 2017

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Media from rhabdomyosarcoma and neuroblastoma cell cultures stimulate in vitro aggregation and fibrillization of amyloid beta-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Metal cations defibrillize the amyloid beta-protein fibrils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Binding of gelsolin, a secretory protein, to amyloid beta-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Amyloid, the presenilins and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Interactions of gelsolin and gelsolin-actin complexes with actin. Effects of calcium on actin nucleation, filament severing, and end blocking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Characterization of beta-amyloid peptide from human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Promotion of synthetic amyloid beta-peptide fibrillization by cell culture media and cessation of fibrillization by serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Alzheimer's disease and soluble A beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Biology of A beta amyloid in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

Evidence that A beta 42 is the real culprit in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902315-X

10.1016/S0006-8993(99)02315-X

7 January 2021

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017